Drug intelligence / Profile preview

dexamethasone + prednisolone

Development stage
Unknown
Lead developer
Merck
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Dexamethasone + prednisolone is a combination of two synthetic glucocorticoid corticosteroids. Both drugs act as anti-inflammatory and immunosuppressive agents by binding to the glucocorticoid receptor, modulating gene expression, and suppressing pro-inflammatory cytokines. This combination has been studied for its enhanced antileukemic activity in pediatric acute lymphoblastic leukemia (ALL), where low-dose dexamethasone added to prednisolone can potentiate cytotoxic effects on leukemic cells compared to either agent alone[1][9]. Both drugs are also used in various inflammatory, allergic, autoimmune, and oncologic conditions due to their ability to reduce inflammation and immune responses[3][5][7]. The rationale for combining them is based on their differing pharmacokinetics and potencies—dexamethasone is more potent with a longer duration of action than prednisolone—and evidence suggests that the combination may overcome resistance seen with single-agent therapy in some patients[1][9].

Other names
dexamethasone-King Fahd General Hospital-postoperative pain-postoperative nausea and vomitingIV dexamethasone and oral prednisolone regimenSteroids for Post-tonsillectomy Morbidities
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on dexamethasone + prednisolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + prednisolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call